4.3 Article

Effect of exercise training on cardiovascular autonomic and muscular function in subclinical Chagas cardiomyopathy: a randomized controlled trial

期刊

CLINICAL AUTONOMIC RESEARCH
卷 31, 期 2, 页码 239-251

出版社

SPRINGER HEIDELBERG
DOI: 10.1007/s10286-020-00721-1

关键词

Chagas cardiomyopathy; Sympathetic nervous system; Exercise; Chagas disease

资金

  1. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/50048-1, 2011/17533-6]
  2. Fundacao Zerbini
  3. Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CNPq) [142179/2013-2]
  4. Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [88881.135917/2016-01]
  5. FAPESP [2013/15651-7]
  6. Conselho Nacional de Pesquisa (CNPq) [140265/2013-9]
  7. CNPq [301867/2010-0, 308068/2011-4]

向作者/读者索取更多资源

Exercise training improves cardiac and peripheral autonomic function in patients with chronic chagasic cardiomyopathy, reducing sympathetic activity in muscles, heart, and vessels, while increasing parasympathetic tone and baroreflex sensitivity. It also leads to increased type I muscle fiber cross-sectional area and oxidative metabolism, as well as decreased atrogin-1 gene expression in skeletal muscle.
Purpose Patients with chronic chagasic cardiomyopathy with preserved ventricular function present with autonomic imbalance. This study evaluated the effects of exercise training (ET) in restoring peripheral and cardiac autonomic control and skeletal muscle phenotype in patients with subclinical chronic chagasic cardiomyopathy. Methods This controlled trial (NCT02295215) included 24 chronic chagasic cardiomyopathy patients who were randomizedinto two groups: those who underwent exercise training (n = 12) and those who continued their usual activities (n = 12). Eight patients completed the exercise training protocol, and 10 patients were clinically followed up for 4 months. Muscular sympathetic nerve activity was measured by microneurography and muscle blood flow (MBF) using venous occlusion plethysmography. The low-frequency component of heart rate variability in normalized units (LFnuHR) reflects sympathetic activity in the heart, and the low-frequency component of systolic blood pressure variability in normalized units reflects sympathetic activity in the vessels. The infusion of vasoactive drugs (phenylephrine and sodium nitroprusside) was used to evaluate cardiac baroreflex sensitivity, and a vastus lateralis muscle biopsy was performed to evaluate atrogin-1 and MuRF-1 gene expression. Results The baroreflex sensitivity for increases (p = 0.002) and decreases (p = 0.02) in systolic blood pressure increased in the ET group. Muscle blood flow also increased only in the ET group (p = 0.004). Only the ET group had reduced resting muscular sympathetic nerve activity levels (p = 0.008) and sympathetic activity in the heart (LFnu;p = 0.004) and vessels (p = 0.04) after 4 months. Regarding skeletal muscle, after 4 months, participants in the exercise training group presented with lower atrogin-1 gene expression than participants who continued their activities as usual (p = 0.001). The reduction in muscular sympathetic nerve activity was positively associated with reduced atrogin-1 (r = 0.86; p = 0.02) and MuRF-1 gene expression (r = 0.64; p = 0.06); it was negatively associated with improved baroreflex sensitivity both for increases (r = -0.72; p = 0.020) and decreases (r = -0.82; p = 0.001) in blood pressure. Conclusions ET improved cardiac and peripheral autonomic function in patients with subclinical chagasic cardiomyopathy. ET reduced MSNA and sympathetic activity in the heart and vessels and increased cardiac parasympathetic tone and baroreflex sensitivity. Regarding peripheral muscle, after 4 months, patients who underwent exercise training had an increased cross-sectional area of type I fibers and oxidative metabolism of muscle fibers, and decreased atrogin-1 gene expression, compared to participants who continued their activities as usual. In addition, the reduction in MSNA was associated with improved cardiac baroreflex sensitivity, reduced sympathetic cardiovascular tone, and reduced atrogin-1 and MuRF-1 gene expression.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据